Evidence map›Paper›PMID 38460018›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2024

Untargeted NMR-based metabolomics analysis of kidney allograft perfusates identifies a signature of delayed graft function.

A Cirillo, M Vandermeulen, P Erpicum, T Pinto Coelho, N Meurisse, O Detry, F Jouret, P de Tullio

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

A CirilloClinical Metabolomics Group, Center for Interdisciplinary Research On Medicines (CIRM), University of Liege, Liege, Belgium. Arianna.cirillo@uliege.be.
M VandermeulenDepartment of Abdominal Surgery and Transplantation, CHU de Liege, University of Liege, Liege, Belgium.
P ErpicumGroupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Metabolism and Cardiovascular Sciences, University of Liege, Liege, Belgium.
T Pinto CoelhoGroupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Metabolism and Cardiovascular Sciences, University of Liege, Liege, Belgium.
N MeurisseDepartment of Abdominal Surgery and Transplantation, CHU de Liege, University of Liege, Liege, Belgium.
O DetryDepartment of Abdominal Surgery and Transplantation, CHU de Liege, University of Liege, Liege, Belgium.
F Jouret *Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Metabolism and Cardiovascular Sciences, University of Liege, Liege, Belgium.
P de Tullio *Clinical Metabolomics Group, Center for Interdisciplinary Research On Medicines (CIRM), University of Liege, Liege, Belgium.
Centre Hospitalier Universitaire de Liège · BEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionKidney transplantation (KTx) necessarily conveys an ischemia/reperfusion (I/R) process, which impacts on allograft outcomes. Delayed graft function (DGF) is defined as a non-decrease of serum creatinine by at least 10% daily on 3 consecutive days during the first 7 days post-KTx. DGF significantly conditions both short- and long-term graft outcomes. Still there is a lack of DGF predictive biomarkers.

objectivesThis study aimed to explore the potential of kidney graft perfusate metabolomics to predict DGF occurrence.

methods49 human perfusates from grafts categorized upon donor type [donation after brain death (DBD)/donation after circulatory death (DCD)] and DGF occurrence and 19 perfusates from a murine model classified upon death type (DBD/DCD) were collected and analyzed by NMR-based metabolomics.

resultsThe multivariate analysis of the murine data highlighted significant differences between perfusate metabolomes of DBD versus DCD. These differences were similarly observed in the human perfusates. After correcting for the type of donor, multivariate analysis of human data demonstrated a metabolomics signature that could be correlated with DGF occurrence.

conclusionsThe metabolome of kidney grafts is influenced by the donor's type in both human and pre-clinical studies and could be correlated with DGF in the human DBD cohort. Thus, metabolomic analysis of perfusate applied prior to KTx may represent a new predictive tool for clinicians in a more personalized management of DGF. Moreover, our data paves the way to better understand the impact of donor's types on the biochemical events occurring between death and the hypothermic storage.

Indexed as

Delayed Graft FunctionGraft SurvivalAllograftsAnimalsHumansKidneyMetabolomicsMiceDelayed graft functionKidney transplantationMetabolomicsNMRPerfusate

Identifiers

PMID38460018
OpenAlexW4392619236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.